Why the study?
Because myocardial immunocompetent cells associate with pathological stage or viability, the study explored relationships between functional recovery after LVAD implantation and immunocompetent cell distribution in non-ischaemic dilated cardiomyopathy.
Does the distribution of immunocompetent cells in the apical myocardium predict functional recovery in non-ischaemic dilated cardiomyopathy patients after LVAD implantation?
Does the distribution of immunocompetent cells in the apical myocardium predict functional recovery in non-ischaemic dilated cardiomyopathy patients after LVAD implantation?
The presence of immunocompetent cells (macrophages and T cells) in the apical myocardium may predict myocardial viability and functional recovery after LVAD implantation in non-ischaemic dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Macrophage and T-cell presence may predict LVEF recovery after LVAD; hypothesis-generating in non-ischaemic cardiomyopathy and needs prospective validation.
OBJECTIVE: Because the presence of immunocompetent cells in the myocardium is associated with the pathological stage and/or myocardial viability, we explored relationships between functional recovery after left ventricular assist device implantation and the distribution of immunocompetent cells in non-ischaemic dilated cardiomyopathy patients. METHODS: We reviewed 50 consecutive dilated cardiomyopathy patients implanted with HeartMate II at our institute between April 2013 and December 2018 who were treated with optimal medical therapy during left ventricular assist device support. Patients were stratified by improvement of the left ventricular ejection fraction at 6 months after implantation: ≥ 10% increase (Gr ≥ 10%), 5-10% (Gr 5-10%), and ≤ 5% (Gr ≤ 5%). T cells and macrophages were evaluated in the apical myocardium after left ventricular assist device implantation. RESULTS: During left ventricular assist device support, 12 patients underwent heart transplantation and 2 patients died. Four patients with Gr ≤ 5% were readmitted because of congestive heart failure, but none with Gr ≥ 10%. Macrophages and T cells in the left ventricular myocardium with Gr ≥ 10% were significantly more present compared to those in other groups. CONCLUSIONS: The distribution of immunocompetent cells in the left ventricular myocardium might predict myocardial viability of this pathology after implantation.
No takes yet. Share an insight, caveat, or question.
Ikuta et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: